跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
力比泰 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Pemetrexed Disodium for Injection
Approved
化学药品
Pemetrexed Disodium for Injection
Eli Lilly Nederland BV
🇨🇳 National Medical Products Administration
Approval Date
Mar 5, 2020
Approval ID
7MazXbRHxMh
Company
Eli Lilly Nederland BV
Type
化学药品
Approval Details
Approval Id
7MazXbRHxMh
Approval Number
H20140662
Generic Name
注射用培美曲塞二钠
Generic Name En
Pemetrexed Disodium for Injection
Trade Name
力比泰
Brand Name
力比泰
Drug Type
化学药品
Dosage Form
注射剂
Strength
500mg(按C20H21N5O6计)
Reg Date
2020-03-05
Expired Date
2025-03-04
Company Name
Eli Lilly Nederland BV
Company Address
Papendorpseweg 83,3528 BJ Utrecht, The Netherlands
Production Company Name
vianex s.a.―plant c
Production Company Address
16th km Marathonos Avenue, Pallini Attiki, 15351 Greece
Company Detail Path
/organization/eli-lilly-nederland-bv
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 5, 2020
Approval ID
7MazXbRHxMh
Type
化学药品
Back to NMPA Approvals